ADC Therapeutics
ADCT
ADCT
83 hedge funds and large institutions have $112M invested in ADC Therapeutics in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 33 increasing their positions, 16 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
35% less capital invested
Capital invested by funds: $173M → $112M (-$60.5M)
50% less call options, than puts
Call options by funds: $51K | Put options by funds: $102K
Holders
83
Holding in Top 10
2
Calls
$51K
Puts
$102K
Top Buyers
| 1 | +$3.85M | |
| 2 | +$2.85M | |
| 3 | +$1.82M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.68M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$1.43M |
Top Sellers
| 1 | -$5.65M | |
| 2 | -$3.66M | |
| 3 | -$2.4M | |
| 4 |
GGH
GCM Grosvenor Holdings
Chicago,
Illinois
|
-$1.29M |
| 5 |
D.E. Shaw & Co
New York
|
-$895K |